Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200062255Phase 4Not yet recruiting
Phase 4, randomised trial of esketamine in postoperative pain (3 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Postoperative pain score. Planned start Jul 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200062255.